Inflammation and the pathophysiology of chronic venous insufficiency

Phlebolymphology

Volumn , Issue 39, 2003, Pages 95-99

  Schmid Schönbein, Geert W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CELL ADHESION MOLECULE; CHEMOTACTIC FACTOR; GROWTH FACTOR; RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; CELL ACTIVATION; CHRONIC VEIN INSUFFICIENCY; DISEASE MARKER; ENDOTHELIUM; EXTRACELLULAR MATRIX; FIBROBLAST; GENETIC RISK; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MAST CELL; METABOLITE; PARENCHYMA; PATHOPHYSIOLOGY; REVIEW; SHEAR STRESS; TISSUE REPAIR; ULCER; VARICOSIS; VEIN VALVE; VENOUS STASIS;

EID: 0037266713     PISSN: 12860107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Schmid-Schönbein GW, Granger DN. Molecular Basis of Microcirculatory Disorders. Paris: Springer Verlag; 2002.
2. Coleridge-Smith PD. Update on chronic-venous-insufficiency-induced inflammatory processes. Angiology. 2001;52 (Suppl 1):S35-S42.
3. Smith PD. Update on chronic-venous-insufficiency-induced inflammatory processes. Angiology. 2001;52 (Suppl 1):S35-S42.
4. Jünger M, Steins A, Hahn M, Hafner HM. Microcirculatory dysfunction in chronic venous insufficiency (CVI). Microcirculation. 2000;7:S3-12.
5. Durán W, Pappas PJ, Schmid-Schönbein GW. Microcirculatory inflammation in chronic venous insufficiency: current status and future directions. Microcirculation. 2000;7:S49-S58.
6. Carpentier PH. [Role of leukocytes in the pathogenesis of trophic venous disorders]. J Mal Vasc. 1998;23:274-276.
7. Vanhoutte PM, Corcaud S, de Montrion C. Venous disease: from pathophysiology to quality of life. Angiology. 1997;48:559-567.
8. Agren MS, Eaglstein WH, Ferguson MW, et al. Causes and effects of the chronic inflammation in venous leg ulcers. Acta Derm Venereol Suppl. 2000;210:3-17.
9. Ono T, Bergan JJ, Schmid-Schönbein GW, Takase S. Monocyte infiltration into venous valves. J Vasc Surg. 1998;27:158-166.
10. Takase S, Schmid-Schönbein GW, Bergan JJ. Leukocyte activation in patients with venous insufficiency. J Vasc Surg. 1999;30:148-156.
11. Peschen M, Lahaye T, Hennig B, Weyl A, Simon JC, Vanscheidt W. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency. Acta Dermato-Venereologica. 1999;79:27-32.
12. Abd-El-Aleem SA, Ferguson MW, Appleton I, et al. Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers. J Pathol. 2000;191:434-442.
13. Krüger-Krasagakes S, Grützkau A, Baghramian R, Henz BM. Interactions of immature human mast cells with extracellular matrix: expression of specific adhesion receptors and their role in cell binding to matrix proteins. J Invest Dermatol. 1996;106:538-543.
14. Lees M, Taylor DJ, Woolley DE. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur J Biochem. 1994;223:171-177.
15. Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. Faseb J. 1997;11:51-59.
16. Pappas PJ, You R, Rameshwar P, et al. Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-beta1 gene expression and protein production. J Vasc Surg. 1999;30:1129-1145.
17. Kähäri VM, Saarialho-Kere U. Matrix metalloproteinases in skin. Exp Dermatol. 1997;6:199-213.
18. Pappas PJ, Gwertzman GA, DeFouw DO, et al. Retinoblastoma protein: a molecular regulator of chronic venous insufficiency. J Surg Res. 1998;76:149-153.
19. Takase S, Lerond L, Bergan JJ, Schmid-Schönbein GW. The inflammatory reaction during venous hypertension in the rat. Microcirculation. 2000;7:1-11.
20. Signorelli SS, Malaponte MG, Di Pino L, Costa MP, Pennisi G, Mazzarino MC. Venous stasis causes release of interleukin 1beta (IL-1beta), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFalpha) by monocyte-macrophage. Clin Hemorheol Microcirc. 2000;22:311-316.
21. Lalka SG, Unthank JL, Nixon JC. Elevated cutaneous leukocyte concentration in a rodent model of acute venous hypertension. J Surg Res. 1998;74:59-63.
22. Labropoulos N, Giannoukas AD, Delis K, et al. Where does venous reflux start? J Vasc Surg. 1997;26:736-742.
23. Resnick N, Yahav H, Khachigian LM, et al. Endothelial gene regulation by laminar shear stress. Adva Exp Med Biol. 1997;430:155-164.
24. Shyy JY, Li YS, Lin MC, et al. Multiple cis-elements mediate shear stress-induced gene expression. J Biomechanics. 1995;28:1451-1457.
25. DePaola N, Davies PF, Pritchard WF, Jr, Florez L, Harbeck N, Polacek DC. Spatial and temporal regulation of gap junction connexin43 in vascular endothelial cells exposed to controlled disturbed flows in vitro. Proc Nat Acad Sci USA. 1999;96:3154-3159.
26. Chen KD, Li YS, Kim M, Li S, Yuan S, Chien S, Shyy JY. Mechanotransduction in response to shear stress. Roles of receptor tyrosine kinases, integrins, and Shc. J Biol Chem. 1999;274:18393-18400.
27. Fukuda S, Yasu T, Predescu DN, Schmid-Schönbein GW. Mechanisms for regulation of fluid shear stress response in circulating leukocytes. Circ Res (UltraRapid Communication). 2000;86:E13-E18.
28. Liu SQ, Moore MM, Glucksberg MR, Mockros LF, Grotberg JB, Mok AP. Partial prevention of monocyte and granulocyte activation in experimental vein grafts by using a biomechanical engineering approach. J Biomech. 1999;32:1165-1175.